Follow the Aspira Pathlab share price and the full directors' dealings record of the company, a listed equity based in India. Shares trade on the IN market, under the supervision of SEBI (PIT + SAST). Market capitalisation: €926.4m. The latest transaction was disclosed on 17 September 2026 (Acquisition). Among the most active insiders: Jay Arvind Bhanushali. The full history is accessible without an account.
8
Insider Decl.
n/a
Thresholds
€1,541
8 ops.
Buy Volume
n/a
n/a
Sell Volume
20Σ signal
Buys €1,541n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 20,502 of 29,068 companies
38.0
score / 100
Value
26
Quality
50
FCF yld0.8%
Earn yld0.1%
EV/EBITDA48.5x
ROE0.4%
Gross mgn77%
Net mgn0.2%
Debt/EBITDA1.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Aspira Pathlab is a company specializing in medical diagnostic services, providing laboratory analysis and health testing. It operates in the XBOM market.